Baidu
map

CCR:上海交大抑癌基因调控机制研究有新进展

2013-03-05 Clin Cancer Res 健康报

上海交通大学基础医学院王建华研究员领衔的课题组新近发现,前列腺癌中抑癌基因HIC1的启动子(基因的一个组成部分,控制基因表达的起始时间和表达程度)如果出现高度甲基化,可能导致其表达沉默而失去抑癌功能。该研究论文日前发表在国际学术刊物《临床癌症研究》上。专家认为,该研究阐明了抑癌基因在调控前列腺癌发生发展中的作用机制。 前列腺癌是男性泌尿生殖系统常见的恶性肿瘤之一,其发病率和死亡率在西方国家男性恶

上海交通大学基础医学院王建华研究员领衔的课题组新近发现,前列腺癌中抑癌基因HIC1的启动子(基因的一个组成部分,控制基因表达的起始时间和表达程度)如果出现高度甲基化,可能导致其表达沉默而失去抑癌功能。该研究论文日前发表在国际学术刊物《临床癌症研究》上。专家认为,该研究阐明了抑癌基因在调控前列腺癌发生发展中的作用机制。

前列腺癌是男性泌尿生殖系统常见的恶性肿瘤之一,其发病率和死亡率在西方国家男性恶性肿瘤中居第二位,近年来,在我国也呈显著上升趋势。上海市前列腺癌发病率已从1990年的2.6/10万上升至2005年的16.1/l0万,位列男性肿瘤的第5位。

研究人员发现,在前列腺癌实体肿瘤组织中抑癌基因HIC1启动子呈现高度甲基化,可能导致其表达沉默而失去抑癌功能。采用5-Aza处理前列腺癌细胞系后,HIC1甲基化降低,HIC1表达上调。在进一步的研究中,科研人员通过体内外实验表明,恢复表达HIC1可显著降低癌细胞增殖、侵袭、转移及成瘤等能力;相反,shRNA沉默表达HIC1后,癌细胞这些特性则被显著增强。

王建华说,该研究有助于为前列腺癌的早期诊断和治疗提供新思路。

doi: 10.1158/1078-0432.CCR-12-2888
PMC:
PMID:

HIC1 modulates prostate cancer progression by epigentic modification

Jianghua Zheng1, Jinglong Wang1, Xueqing Sun1, Mingang Hao1, Tao Ding2, Dan Xiong1, Xiumin Wang1, Yu Zhu3, Gang Xiao1, Guangcun Cheng1, Meizhong Zhao4, Jian Zhang5, and Jianhua Wang1,*

Purpose: Prostate cancer (PCa) is the second leading cause of cancer deaths among men in Western counties, which has been also occurred in Chinese male with markedly increasing incidence in recent years. Although the mechanism underlying its progression still remains unclear, epigenetic modifications are important ethological parameters. Exrimental Design: The methylation status of HIC1 promoter were assayed in cell lines, tissues and plasma of PCa patients by using MSP-PCR and bisulfate sequencing (BSP). The ability of HIC1 to regulate proliferation, migration and invasion was assessed by MTT, scratch healing assay and reconstituted extracellular matrices in porous culture chambers. Tumorigenesis,metastases and bone destruction were analyzed in mice bearing PCa cells restoring HIC1 by using Xenogen IVIS with radiographic system and small-animal PET-CT images. Microarrays were searched for genes that had correlated expression with HIC1 mRNA. Results: The methylation status of 11 CpG sites within HIC1 promoter were abundantly methylated in cell lines, tissues and plasma of PCa patients compared with those of respective normal controls. Restoring HIC1 expression in PCa cells markedly inhibited proliferation, migration, and invasion and induced the apoptosis in these cells. Moreover, mice bearing PCa-restoring HIC1 cells had a marked effect on reducing tumor growth,multiple tissue metastases and bone destruction. Notably, we also identified that the chemokine receptor CXCR7 is a direct downstream target gene of HIC1. Conclusions: These findings suggest that therapies targeting epigenetic events regulating HIC1 expression may provide a more effective strategy for PCa treatment.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2056114, encodeId=398a2056114c0, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 27 16:37:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640622, encodeId=103a1640622d1, content=<a href='/topic/show?id=fd575494e5e' target=_blank style='color:#2F92EE;'>#抑癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54947, encryptionId=fd575494e5e, topicName=抑癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Nov 21 12:37:00 CST 2013, time=2013-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323225, encodeId=437613232255f, content=<a href='/topic/show?id=9934549500e' target=_blank style='color:#2F92EE;'>#抑癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54950, encryptionId=9934549500e, topicName=抑癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373832, encodeId=5b4613e38329a, content=<a href='/topic/show?id=3644e1286f1' target=_blank style='color:#2F92EE;'>#癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71286, encryptionId=3644e1286f1, topicName=癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee7b365, createdName=zhucaizhong7766, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497593, encodeId=2303149e5939f, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553804, encodeId=c13c1553804b0, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557653, encodeId=6e33155e653ea, content=<a href='/topic/show?id=530341903b2' target=_blank style='color:#2F92EE;'>#基因调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41903, encryptionId=530341903b2, topicName=基因调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2056114, encodeId=398a2056114c0, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 27 16:37:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640622, encodeId=103a1640622d1, content=<a href='/topic/show?id=fd575494e5e' target=_blank style='color:#2F92EE;'>#抑癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54947, encryptionId=fd575494e5e, topicName=抑癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Nov 21 12:37:00 CST 2013, time=2013-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323225, encodeId=437613232255f, content=<a href='/topic/show?id=9934549500e' target=_blank style='color:#2F92EE;'>#抑癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54950, encryptionId=9934549500e, topicName=抑癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373832, encodeId=5b4613e38329a, content=<a href='/topic/show?id=3644e1286f1' target=_blank style='color:#2F92EE;'>#癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71286, encryptionId=3644e1286f1, topicName=癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee7b365, createdName=zhucaizhong7766, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497593, encodeId=2303149e5939f, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553804, encodeId=c13c1553804b0, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557653, encodeId=6e33155e653ea, content=<a href='/topic/show?id=530341903b2' target=_blank style='color:#2F92EE;'>#基因调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41903, encryptionId=530341903b2, topicName=基因调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2056114, encodeId=398a2056114c0, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 27 16:37:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640622, encodeId=103a1640622d1, content=<a href='/topic/show?id=fd575494e5e' target=_blank style='color:#2F92EE;'>#抑癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54947, encryptionId=fd575494e5e, topicName=抑癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Nov 21 12:37:00 CST 2013, time=2013-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323225, encodeId=437613232255f, content=<a href='/topic/show?id=9934549500e' target=_blank style='color:#2F92EE;'>#抑癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54950, encryptionId=9934549500e, topicName=抑癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373832, encodeId=5b4613e38329a, content=<a href='/topic/show?id=3644e1286f1' target=_blank style='color:#2F92EE;'>#癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71286, encryptionId=3644e1286f1, topicName=癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee7b365, createdName=zhucaizhong7766, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497593, encodeId=2303149e5939f, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553804, encodeId=c13c1553804b0, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557653, encodeId=6e33155e653ea, content=<a href='/topic/show?id=530341903b2' target=_blank style='color:#2F92EE;'>#基因调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41903, encryptionId=530341903b2, topicName=基因调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2056114, encodeId=398a2056114c0, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 27 16:37:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640622, encodeId=103a1640622d1, content=<a href='/topic/show?id=fd575494e5e' target=_blank style='color:#2F92EE;'>#抑癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54947, encryptionId=fd575494e5e, topicName=抑癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Nov 21 12:37:00 CST 2013, time=2013-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323225, encodeId=437613232255f, content=<a href='/topic/show?id=9934549500e' target=_blank style='color:#2F92EE;'>#抑癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54950, encryptionId=9934549500e, topicName=抑癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373832, encodeId=5b4613e38329a, content=<a href='/topic/show?id=3644e1286f1' target=_blank style='color:#2F92EE;'>#癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71286, encryptionId=3644e1286f1, topicName=癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee7b365, createdName=zhucaizhong7766, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497593, encodeId=2303149e5939f, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553804, encodeId=c13c1553804b0, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557653, encodeId=6e33155e653ea, content=<a href='/topic/show?id=530341903b2' target=_blank style='color:#2F92EE;'>#基因调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41903, encryptionId=530341903b2, topicName=基因调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2056114, encodeId=398a2056114c0, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 27 16:37:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640622, encodeId=103a1640622d1, content=<a href='/topic/show?id=fd575494e5e' target=_blank style='color:#2F92EE;'>#抑癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54947, encryptionId=fd575494e5e, topicName=抑癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Nov 21 12:37:00 CST 2013, time=2013-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323225, encodeId=437613232255f, content=<a href='/topic/show?id=9934549500e' target=_blank style='color:#2F92EE;'>#抑癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54950, encryptionId=9934549500e, topicName=抑癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373832, encodeId=5b4613e38329a, content=<a href='/topic/show?id=3644e1286f1' target=_blank style='color:#2F92EE;'>#癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71286, encryptionId=3644e1286f1, topicName=癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee7b365, createdName=zhucaizhong7766, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497593, encodeId=2303149e5939f, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553804, encodeId=c13c1553804b0, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557653, encodeId=6e33155e653ea, content=<a href='/topic/show?id=530341903b2' target=_blank style='color:#2F92EE;'>#基因调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41903, encryptionId=530341903b2, topicName=基因调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2056114, encodeId=398a2056114c0, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 27 16:37:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640622, encodeId=103a1640622d1, content=<a href='/topic/show?id=fd575494e5e' target=_blank style='color:#2F92EE;'>#抑癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54947, encryptionId=fd575494e5e, topicName=抑癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Nov 21 12:37:00 CST 2013, time=2013-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323225, encodeId=437613232255f, content=<a href='/topic/show?id=9934549500e' target=_blank style='color:#2F92EE;'>#抑癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54950, encryptionId=9934549500e, topicName=抑癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373832, encodeId=5b4613e38329a, content=<a href='/topic/show?id=3644e1286f1' target=_blank style='color:#2F92EE;'>#癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71286, encryptionId=3644e1286f1, topicName=癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee7b365, createdName=zhucaizhong7766, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497593, encodeId=2303149e5939f, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553804, encodeId=c13c1553804b0, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557653, encodeId=6e33155e653ea, content=<a href='/topic/show?id=530341903b2' target=_blank style='color:#2F92EE;'>#基因调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41903, encryptionId=530341903b2, topicName=基因调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2056114, encodeId=398a2056114c0, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Aug 27 16:37:00 CST 2013, time=2013-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640622, encodeId=103a1640622d1, content=<a href='/topic/show?id=fd575494e5e' target=_blank style='color:#2F92EE;'>#抑癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54947, encryptionId=fd575494e5e, topicName=抑癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Nov 21 12:37:00 CST 2013, time=2013-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323225, encodeId=437613232255f, content=<a href='/topic/show?id=9934549500e' target=_blank style='color:#2F92EE;'>#抑癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54950, encryptionId=9934549500e, topicName=抑癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e622500011, createdName=12498484m46(暂无昵称), createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373832, encodeId=5b4613e38329a, content=<a href='/topic/show?id=3644e1286f1' target=_blank style='color:#2F92EE;'>#癌基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71286, encryptionId=3644e1286f1, topicName=癌基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee7b365, createdName=zhucaizhong7766, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497593, encodeId=2303149e5939f, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553804, encodeId=c13c1553804b0, content=<a href='/topic/show?id=0ba81988692' target=_blank style='color:#2F92EE;'>#上海交大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19886, encryptionId=0ba81988692, topicName=上海交大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a6414444709, createdName=gao_jian4222, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557653, encodeId=6e33155e653ea, content=<a href='/topic/show?id=530341903b2' target=_blank style='color:#2F92EE;'>#基因调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41903, encryptionId=530341903b2, topicName=基因调控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 07 04:37:00 CST 2013, time=2013-03-07, status=1, ipAttribution=)]

相关资讯

Cancer Res.:鼻咽癌细胞系中发现干细胞样细胞亚群新特征

近日来自南方医科大学的研究人员在鼻咽癌细胞系中发现并确定一类特殊的干细胞样细胞亚群的特征,他们认为这些细胞可能是导致鼻咽癌放疗后复发及治疗耐受的重要原因。研究发现发表在国际权威肿瘤学杂志《Cancer Research》(2011年IF为7.856)上。 领导这一研究的是南方医科大学教授、中国科学院院士姚开泰。他是我国鼻咽癌研究的主要奠基人之一,长期从事分子肿瘤病理学研究,在肿瘤(尤其鼻咽癌)的

Ann Oncol:肺癌将取代乳腺癌成为欧洲女性头号杀手

欧洲部分癌症死亡率统计 对于欧盟及其人口较多的六个国家2011年和2012年的癌症死亡率的统计数据已经发布于2013年最新一期Annals of Oncology February杂志。 研究人员使用对数泊松计数数据的连接点模型和世界卫生组织(WHO)死亡率和人口数据库,对2013年所有癌症和选定的癌症死亡的数目及年龄标准化死亡率(ASRS)进行估算。 2013年在欧盟国家的癌症死亡人数的预

Hepatology:MicroRNA-10a参与肝癌细胞转移

来自天津医科大学和中山大学癌症中心的研究人员在新研究中揭示:一种名为MicroRNA-10a的miRNA通过调控EphA4受体介导的上皮间质转化和细胞粘附,参与了肝癌细胞转移过程。相关论文发表在在国际著名肝脏疾病杂志Hepatology上(最新影响因子11.665)上。 天津医科大学的汤华(Hua Tang)教授和中山大学的李升平(Shengping Li)副教授为论文的共同通讯作者。前者主要从

Nature:华人学者操刀明星抑癌基因新解读

肿瘤抑制基因p53是人类肿瘤中突变最频繁的单个基因,其重要性已成为研究领域的共识。p53能通过促进细胞老化来防止细胞癌变,通常情况下发生突变或有危险的细胞会收到信号让其停止生长或死亡,但缺乏p53的细胞会无视这些信号。 显而易见,p53通路对于药物研发人员来说是相当具有吸引力的靶标。但目前,把标p53通路的策略往往难以实现。这是因为绝大多数p53调控蛋白是通过蛋白互作来执行功能的,这样的作用机制

JAMA:确认了与根除和胃癌有关的细菌的因素

胃腺癌是全球癌症死亡的第二大原因。尽管胃癌发病率在某些地区正在下降,但因为在诸如拉丁美洲和东亚等高发病率地区人口的增长和老化,其死亡人数预计会在未来的几十年中增加。幽门螺旋杆菌感染了世界上超过一半的成年人,而这种细菌的慢性感染是胃癌的主要风险因素,据估计它占了全球所有病例的三分之二。 据发表在2月13日出版的《美国医学会杂志》上的一则研究披露,在一项对拉丁美洲7个不同社区人群的根除幽门螺旋杆菌(

Lancet:推荐结直肠癌疑似患者**CT结肠镜成像诊断方法

根据年龄和性别分组对结直肠癌或巨大息肉的探查率 在结直肠肿瘤患者的诊断过程中,虽然钡剂灌肠(BE)被广泛用于结直肠肿瘤患者的诊断,但是其准确性和可接受性还存在争议。而CT结肠镜(CTC)或许是一个更敏感、更易于接受的选择。本研究旨在比较在有症状的患者中,CTC和BE对结直肠癌或巨大息肉患者诊断的临床价值。来自英国伦敦大学的Steve Halligan等针对上述问题展开深入研究,结果发表在Lanc

Baidu
map
Baidu
map
Baidu
map